Please assess the completion status of the following clinical trial:

Trial Title: VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients over 18 years old.~* Patients with endometrial cancer, with histological type I and II, regardless of the degree of differentiation.~* Patients with stage I, II or III endometrial cancer according to the FIGO classification.~* Patients treated with high-dose-rate vaginal cuff brachytherapy, with curative intent.~* Patients affiliated or entitled to a social security scheme.~* Patients who received information about the study and co-signed with the investigator the consent to participate at the study.~Exclusion Criteria:~* Patients with stage IV endometrial cancer according to FIGO classification.~* Patients presenting recurrence of endometrial cancer.~* Pregnant or nursing women.~* Patients under protection of justice or unable to give consent.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Virtual Reality Helmet (Type: EXPERIMENTAL): Patients will use a virtual reality helmet during brachytherapy applicator's setting up. The use of virtual reality helmet has already been assessed during oncologic treatments, and seems to reduce pain and anxiety. The use of virtual reality helmet has never been assessed to reduce the pain or anxiety associated with brachytherapy applicators' setting up.
- No Virtual Reality Helmet (Type: ACTIVE_COMPARATOR): Patient wont use virtual reality helmet during brachytherapy applicator setting up, as in current practice.

Based on this trial design, predict the completion outcome and termination type (if applicable).